Cargando…

US-guided percutaneous laser ablation of refractory metastatic retroperitoneal lesions: A care-compliant case report

RATIONALE: Retroperitoneal metastatic lymph node is rare but severe, which has important structures like the gastrointestinal tract and large blood vessels around and may challenge excision, inducing serious complications like hemorrhage, intestinal adhesion, and even death after injury. PATIENT CON...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Guo, Jiang, Tian’an
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403096/
https://www.ncbi.nlm.nih.gov/pubmed/28403099
http://dx.doi.org/10.1097/MD.0000000000006597
_version_ 1783231369865854976
author Tian, Guo
Jiang, Tian’an
author_facet Tian, Guo
Jiang, Tian’an
author_sort Tian, Guo
collection PubMed
description RATIONALE: Retroperitoneal metastatic lymph node is rare but severe, which has important structures like the gastrointestinal tract and large blood vessels around and may challenge excision, inducing serious complications like hemorrhage, intestinal adhesion, and even death after injury. PATIENT CONCERNS: We described the case of a 60-year-old man with a history of right liver resection in 2010, pulmonary wedge resection in 2012, and transarterial chemoembolization twice in 2014, in which the postoperative pathology suggested the mixed liver cancer, and poorly differentiated lung cancer from liver metastasis. DIAGNOSES: Preoperative magnetic resonance (MR) imaging scan showed a refractory retroperitoneal metastatic lymph node. INTERVENTIONS: Then this patient repeatedly received 4 ablations with US-guided laser ablation within a month. OUTCOMES: After 4 ablations due to residual tumor, MR, and CT images of 5-month follow-up showed the partial response. No obvious side effects were discovered in this case during these procedures. LESSONS: This suggested US-guided laser ablation appears to be a useful technique for retroperitoneal metastatic lymph node with poor general condition or those refusing surgical therapy.
format Online
Article
Text
id pubmed-5403096
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-54030962017-04-28 US-guided percutaneous laser ablation of refractory metastatic retroperitoneal lesions: A care-compliant case report Tian, Guo Jiang, Tian’an Medicine (Baltimore) 5700 RATIONALE: Retroperitoneal metastatic lymph node is rare but severe, which has important structures like the gastrointestinal tract and large blood vessels around and may challenge excision, inducing serious complications like hemorrhage, intestinal adhesion, and even death after injury. PATIENT CONCERNS: We described the case of a 60-year-old man with a history of right liver resection in 2010, pulmonary wedge resection in 2012, and transarterial chemoembolization twice in 2014, in which the postoperative pathology suggested the mixed liver cancer, and poorly differentiated lung cancer from liver metastasis. DIAGNOSES: Preoperative magnetic resonance (MR) imaging scan showed a refractory retroperitoneal metastatic lymph node. INTERVENTIONS: Then this patient repeatedly received 4 ablations with US-guided laser ablation within a month. OUTCOMES: After 4 ablations due to residual tumor, MR, and CT images of 5-month follow-up showed the partial response. No obvious side effects were discovered in this case during these procedures. LESSONS: This suggested US-guided laser ablation appears to be a useful technique for retroperitoneal metastatic lymph node with poor general condition or those refusing surgical therapy. Wolters Kluwer Health 2017-04-14 /pmc/articles/PMC5403096/ /pubmed/28403099 http://dx.doi.org/10.1097/MD.0000000000006597 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle 5700
Tian, Guo
Jiang, Tian’an
US-guided percutaneous laser ablation of refractory metastatic retroperitoneal lesions: A care-compliant case report
title US-guided percutaneous laser ablation of refractory metastatic retroperitoneal lesions: A care-compliant case report
title_full US-guided percutaneous laser ablation of refractory metastatic retroperitoneal lesions: A care-compliant case report
title_fullStr US-guided percutaneous laser ablation of refractory metastatic retroperitoneal lesions: A care-compliant case report
title_full_unstemmed US-guided percutaneous laser ablation of refractory metastatic retroperitoneal lesions: A care-compliant case report
title_short US-guided percutaneous laser ablation of refractory metastatic retroperitoneal lesions: A care-compliant case report
title_sort us-guided percutaneous laser ablation of refractory metastatic retroperitoneal lesions: a care-compliant case report
topic 5700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403096/
https://www.ncbi.nlm.nih.gov/pubmed/28403099
http://dx.doi.org/10.1097/MD.0000000000006597
work_keys_str_mv AT tianguo usguidedpercutaneouslaserablationofrefractorymetastaticretroperitoneallesionsacarecompliantcasereport
AT jiangtianan usguidedpercutaneouslaserablationofrefractorymetastaticretroperitoneallesionsacarecompliantcasereport